Holen Sie sich die Stockscreener-App
10.70
6.67%
-0.765
Handel nachbörslich:
11.25
0.55
+5.14%
Schlusskurs vom Vortag:
$11.46
Offen:
$11.25
24-Stunden-Volumen:
2,582
Relative Volume:
0.06
Marktkapitalisierung:
$37.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-53.45M
KGV:
-0.4929
EPS:
-21.71
Netto-Cashflow:
$-31.81M
1W Leistung:
-5.64%
1M Leistung:
-1.92%
6M Leistung:
+0.75%
1J Leistung:
-19.25%
1-Tages-Spanne:
$10.70
$11.25
1-Wochen-Bereich:
$10.65
$12.03
52-Wochen-Spanne:
$5.9999
$18.17
Surrozen Inc Stock (SRZN) Company Profile
Firmenname
Surrozen Inc
Sektor
Branche
Telefon
650-475-2820
Adresse
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Vergleichen Sie SRZN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
10.70 | 37.26M | 0 | -53.45M | -31.81M | -21.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-03 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-09-15 | Eingeleitet | Guggenheim | Buy |
| 2021-09-07 | Eingeleitet | Stifel | Buy |
Surrozen Inc Aktie (SRZN) Neueste Nachrichten
(SRZN) Trading Signals - Stock Traders Daily
H.C. Wainwright sets $32 target on Surrozen stock with Buy rating - MSN
How To Trade (SRZN) - Stock Traders Daily
HC Wainwright Predicts Surrozen FY2024 Earnings - Defense World
Surrozen (NASDAQ:SRZN) Research Coverage Started at HC Wainwright - Defense World
HC Wainwright & Co. Initiates Coverage of Surrozen (SRZN) with Buy Recommendation - MSN
This Worthington Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
HC Wainwright Initiates Coverage on Surrozen With Buy Rating, $32 Price Target -January 30, 2025 at 08:15 am EST - Marketscreener.com
(SRZN) Trading Advice - Stock Traders Daily
REGENTS OF THE UNIVERSITY OF CALIFORNIA Acquires Shares in Surro - GuruFocus.com
Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation - Yahoo Finance
(SRZN) Trading Report - Stock Traders Daily
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAditxt (NASDAQ:ADTX), Aclarion (NASDAQ:ACON) - Benzinga
Financial Analysis: Recursion Pharmaceuticals (NASDAQ:RXRX) versus Surrozen (NASDAQ:SRZN) - Defense World
Surrozen exec vice president sells $14,642 in stock - Investing.com
Surrozen exec vice president sells $14,642 in stock By Investing.com - Investing.com UK
Surrozen's CFO and COO sells $20,513 in stock - Investing.com
Surrozen's CFO and COO sells $20,513 in stock By Investing.com - Investing.com UK
Surrozen (NASDAQ:SRZN) Upgraded by Guggenheim to “Buy” Rating - Defense World
Surrozen stock soars to 52-week high, hits $16.35 - Investing.com
(SRZN) Investment Analysis and Advice - Stock Traders Daily
Financial Review: Surrozen (NASDAQ:SRZN) & Vericel (NASDAQ:VCEL) - Defense World
Learn to Evaluate (SRZN) using the Charts - Stock Traders Daily
When the Price of (SRZN) Talks, People Listen - Stock Traders Daily
Companies Like Surrozen (NASDAQ:SRZN) Could Be Quite Risky - Simply Wall St
Contrasting Vigil Neuroscience (NASDAQ:VIGL) and Surrozen (NASDAQ:SRZN) - Defense World
Surrozen, Inc.: Q3 2024 Earnings Overview - TipRanks
Trading (SRZN) With Integrated Risk Controls - Stock Traders Daily
Alyeska Investment Group L.P. Expands Portfolio with Surrozen In - GuruFocus.com
Surrozen (NASDAQ:SRZN) Stock Price Down 7% – Here’s Why - Defense World
Stonepine Capital Management, LLC Increases Stake in Surrozen Inc - GuruFocus.com
Goldman Sachs Group Inc's Strategic Investment in Surrozen Inc - GuruFocus.com
Surrozen to Present at Upcoming Healthcare Investor Conferences - The Manila Times
Surrozen (SRZN) to Present at Guggenheim and Stifel Healthcare Conferences | SRZN Stock News - StockTitan
Surrozen Provides Third Quarter 2024 Financial Results and Business Update - ForexTV.com
Surrozen partners with TCGFB for lung disease therapy By Investing.com - Investing.com Canada
Surrozen partners with TCGFB for lung disease therapy - Investing.com India
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis - The Manila Times
The Column Group's biotech taps Surrozen for lung disease research pact - Fierce Biotech
StemPoint Capital LP Increases Stake in Surrozen Inc - GuruFocus.com
Trend Tracker for (SRZN) - Stock Traders Daily
Surrozen (NASDAQ:SRZN) Trading Up 4.3% – Here’s What Happened - Defense World
This Week's Bay Area Deal Sheet (October 10, 2024) - Bisnow
Surrozen extends South San Francisco headquarters lease By Investing.com - Investing.com Australia
Surrozen extends South San Francisco headquarters lease - Investing.com India
187,206 Shares in Surrozen, Inc. (NASDAQ:SRZN) Purchased by Nantahala Capital Management LLC - Defense World
Stonepine Capital Management LLC Invests $724,000 in Surrozen, Inc. (NASDAQ:SRZN) - Defense World
CVI Holdings LLC Makes New Investment in Surrozen, Inc. (NASDAQ:SRZN) - Defense World
Column Group LLC Makes New Investment in Surrozen, Inc. (NASDAQ:SRZNW) - Defense World
Boehringer Ingelheim to advance SZN-413 for retinal diseases - BioWorld Online
Finanzdaten der Surrozen Inc-Aktie (SRZN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Surrozen Inc-Aktie (SRZN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Williams Charles O | CFO and COO |
Jan 03 '25 |
Sale |
17.37 |
1,181 |
20,514 |
8,982 |
| Kutzkey Tim | Director |
Apr 04 '24 |
Buy |
15.50 |
193,548 |
2,999,994 |
332,885 |
| COLUMN GROUP III GP, LP | 10% Owner |
Apr 04 '24 |
Buy |
15.50 |
193,548 |
2,999,994 |
332,885 |
6.45%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):